| Title | Therapeutic Advances in Cardiovascular Disease |
| Abbreviation | Ther. Adv. Cardiovasc. Dis. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Cardiology and Cardiovascular Medicine (Q2); Pharmacology (medical) (Q2) |
| h-index | 37 |
| Overall Rank/Ranking | 6149 |
| SCImago Journal Rank (SJR) | 0.784 |
| Impact Score | 2.22 |
| Publisher | SAGE Publications Ltd |
| Country | United Kingdom |
| ISSN | 17539455, 17539447 |
| Best Quartile | Q2 |
| Coverage History | 2007-2022 |
Therapeutic Advances in Cardiovascular Disease is a journal covering the technologies/fields/categories related to Cardiology and Cardiovascular Medicine (Q2); Pharmacology (medical) (Q2). It is published by SAGE Publications Ltd. The overall rank of Therapeutic Advances in Cardiovascular Disease is 6149. According to SCImago Journal Rank (SJR), this journal is ranked 0.784. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 37. The best quartile for this journal is Q2.
The ISSN of Therapeutic Advances in Cardiovascular Disease journal is 17539455, 17539447. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Therapeutic Advances in Cardiovascular Disease is cited by a total of 165 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Therapeutic Advances in Cardiovascular Disease is 2.22, which is computed in 2023 as per its definition. Therapeutic Advances in Cardiovascular Disease IF is decreased by a factor of 0.75 and approximate percentage change is -25.25% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Therapeutic Advances in Cardiovascular Disease is 2.22. If the same downward trend persists, Impact IF may fall in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2.22 |
| 2021 | 2.97 |
| 2020 | 2.36 |
| 2019 | 1.73 |
| 2018 | 1.83 |
| 2017 | 1.70 |
| 2016 | 1.52 |
| 2015 | 1.61 |
| 2014 | 1.66 |
Therapeutic Advances in Cardiovascular Disease has an h-index of 37. It means 37 articles of this journal have more than 37 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Therapeutic Advances in Cardiovascular Disease is 17539455, 17539447. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Therapeutic Advances in Cardiovascular Disease is 6149. According to SCImago Journal Rank (SJR), this journal is ranked 0.784. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.784 |
| 2021 | 0.816 |
| 2020 | 1.164 |
| 2019 | 0.599 |
| 2018 | 0.537 |
| 2017 | 0.535 |
| 2016 | 0.500 |
| 2015 | 0.595 |
| 2014 | 0.686 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 6149 |
| 2021 | 5567 |
| 2020 | 3466 |
| 2019 | 8268 |
| 2018 | 8942 |
| 2017 | 8737 |
| 2016 | 9279 |
| 2015 | 7951 |
| 2014 | 6799 |
Therapeutic Advances in Cardiovascular Disease is published by SAGE Publications Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2007-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Therapeutic Advances in Cardiovascular Disease is Ther. Adv. Cardiovasc. Dis.. This abbreviation ('Ther. Adv. Cardiovasc. Dis.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cardiology and Cardiovascular Medicine (Q2); Pharmacology (medical) (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Therapeutic Advances in Cardiovascular Disease latest impact IF is 2.22. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 2.97 (2021) and 1.52 (2016), respectively, in the last 9 years. Moreover, its average IS is 1.96 in the previous 9 years.
The Therapeutic Advances in Cardiovascular Disease has an SJR (SCImago Journal Rank) of 0.784, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.164 in 2020 and the lowest being 0.500 in 2016. Furthermore, the average SJR of the Therapeutic Advances in Cardiovascular Disease over the previous 9-year period stands at 1.96.
The latest h-index of the Therapeutic Advances in Cardiovascular Disease is 37.
The Therapeutic Advances in Cardiovascular Disease is published by the SAGE Publications Ltd, with its country of publication being the United Kingdom.
The Therapeutic Advances in Cardiovascular Disease is currently ranked 6149 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 3466 in 2020 and its lowest position of 9279 in 2016.
The standard ISO4 abbreviation for the Therapeutic Advances in Cardiovascular Disease is Ther. Adv. Cardiovasc. Dis..
Therapeutic Advances in Cardiovascular Disease is classified as a journal that the SAGE Publications Ltd publishes.
The Therapeutic Advances in Cardiovascular Disease encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Therapeutic Advances in Cardiovascular Disease is assigned the following International Standard Serial Numbers (ISSN): 17539455, 17539447.
The best quartile for the Therapeutic Advances in Cardiovascular Disease is Q2 (2022).
The Therapeutic Advances in Cardiovascular Disease coverage history can be summarized as follows: 2007-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Historia | journal | 27560 | Universidade Estadual Paulista | 7 | 0.02 |
| Proceedings of the International Symposium on Power Semiconductor Devices and ICs | conference and proceedings | 7015 | 49 | 2.14 | |
| Istanbul University - Journal of Electrical and Electronics Engineering | journal | 24654 | University of Istanbul | 0 | 0.00 |
| Journal of Classical Sociology | journal | 13766 | SAGE Publications Ltd | 27 | 0.83 |
| International Journal of Applied Linguistics | journal | 7321 | Wiley-Blackwell Publishing Ltd | 51 | 2.00 |
| European Surgery - Acta Chirurgica Austriaca | journal | 16873 | Springer Medizin | 23 | 0.58 |
| Exploration Geophysics | journal | 16383 | Taylor and Francis Ltd. | 48 | 1.17 |
| European Journal of Wildlife Research | journal | 8709 | Springer Verlag | 56 | 1.99 |
| Psycho-Oncologie | journal | 24009 | Springer Paris | 11 | 0.13 |
| Cuadernos de historia (Santiago, Chile) | journal | 20081 | Universidad de Chile | 4 | 0.25 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2.22 |
| 2021 | 2.97 |
| 2020 | 2.36 |
| 2019 | 1.73 |
| 2018 | 1.83 |
| 2017 | 1.70 |
| 2016 | 1.52 |
| 2015 | 1.61 |
| 2014 | 1.66 |
